NASDAQ:SILKSilk Road Medical Stock Price, Forecast & News

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SILK shares have increased by 4.4% and is now trading at $38.79. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Silk Road Medical.

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Silk Road Medical.

Silk Road Medical Inc (NASDAQ:SILK) released its quarterly earnings data on Thursday, April, 30th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.31) by $0.01. The company earned $18.93 million during the quarter, compared to analysts' expectations of $19.79 million. Silk Road Medical had a negative net margin of 54.94% and a negative return on equity of 44.17%. The business's revenue was up 48.3% on a year-over-year basis. During the same period last year, the business earned ($20.12) earnings per share. View Silk Road Medical's earnings history.

3 Wall Street analysts have issued 1-year price objectives for Silk Road Medical's stock. Their forecasts range from $47.00 to $52.00. On average, they anticipate Silk Road Medical's share price to reach $49.67 in the next year. This suggests a possible upside of 28.0% from the stock's current price. View analysts' price targets for Silk Road Medical.

Media headlines about SILK stock have been trending negative on Thursday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Silk Road Medical earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutSilk Road Medical.

Silk Road Medical saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,270,000 shares, an increase of 5.6% from the April 15th total of 2,150,000 shares. Based on an average daily volume of 323,700 shares, the short-interest ratio is currently 7.0 days. Currently, 9.8% of the shares of the stock are short sold. View Silk Road Medical's Current Options Chain.

Some companies that are related to Silk Road Medical include Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Irhythm Technologies (IRTC), NuVasive (NUVA), Merit Medical Systems (MMSI), Inovio Pharmaceuticals (INO), Inspire Medical Systems (INSP), Cantel Medical (CMD), Glaukos (GKOS), AtriCure (ATRC), Luminex (LMNX), Shockwave Medical (SWAV), Cardiovascular Systems (CSII) and Axonics Modulation Technologies (AXNX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Honeywell International (HON), Splunk (SPLK), Thermo Fisher Scientific (TMO), CVS Health (CVS), DexCom (DXCM), Raytheon Technologies (RTX) and Veeva Systems (VEEV).

(SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Silk Road Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Capital World Investors (5.64%), BlackRock Inc. (5.29%), Janus Henderson Group PLC (5.22%), Alliancebernstein L.P. (4.63%), Wasatch Advisors Inc. (4.60%) and Jennison Associates LLC (4.26%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp. View institutional ownership trends for Silk Road Medical.

SILK stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Janus Henderson Group PLC, Alyeska Investment Group L.P., Atom Investors LP, TimesSquare Capital Management LLC, Cannell Peter B & Co. Inc., Rhenman & Partners Asset Management AB, and Nuveen Asset Management LLC. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, and Richard Ruedy. View insider buying and selling activity for Silk Road Medical.

SILK stock was bought by a variety of institutional investors in the last quarter, including Capital World Investors, Wasatch Advisors Inc., Invesco Ltd., Capital International Investors, Frontier Capital Management Co. LLC, Clearbridge Investments LLC, BlackRock Inc., and Thrivent Financial for Lutherans. View insider buying and selling activity for Silk Road Medical.

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SILK stock can currently be purchased for approximately $38.79.

Silk Road Medical has a market capitalization of $1.22 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 176 workers across the globe.

The official website for Silk Road Medical is www.silkroadmed.com.

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]